Evaluation of efficacy and safety of aceclofenac injection in the treatment of acute lumbago: a randomised comparative open-labeled multi-centric trial

Venus Remedies Limited (India)0 个研究点目标入组 300 人开始时间: 2006年10月3日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Patients of either sex, aged over 18 years suffering from acute lumbago (that began less than 48 hours before study entry)
•2. Pain intensity more than 50 mm on a 100 mm Visual Analogue Scale (VAS)

•Patients with history of:
•1. Recurrent peptic ulcer or duodenal ulcer
•2. Gastrointestinal bleeding or other bleeding disorders
•3. Significant renal or hepatic impairment
•4. Any significant abnormality on preclinical trial screening
•5. Pregnant and lactating mothers
•6. Patients requiring aspirin at any dose, corticosteroids, anticoagulants, ticlopidine hydrochloride or other drugs affecting platelet function and coagulation, and patients taking hormonal contraceptives or patients allergic to Non Steroidal Anti-Inflammatory Drugs (NSAIDs)

发起方

Venus Remedies Limited (India)